Type 1 diabetes has a strong genetic component, but it is not purely genetic. Over 75 genetic regions influence the risk of developing the condition, with the most powerful ones located in a cluster of immune system genes called the HLA region. However, most people who carry high-risk genes never develop type 1 diabetes, and identical twins share the diagnosis only about half the time. Genes load the gun, but something in the environment pulls the trigger.
The HLA Genes: Where Most Risk Lives
The biggest genetic players in type 1 diabetes are genes that control how your immune system identifies threats. These genes, part of the HLA system, produce proteins on the surface of your cells that help the immune system distinguish your own tissue from invaders like bacteria or viruses. When certain versions of these genes are present, the immune system is more likely to mistakenly attack the insulin-producing cells in the pancreas.
Two gene variants carry the most risk: HLA-DR3 (paired with a variant called DQ2) and HLA-DR4 (paired with DQ8). Having one of these combinations raises your odds meaningfully. Having DR4-DQ8, for example, increases risk roughly eightfold compared to the general population. But the highest risk belongs to people who inherit one copy of each, the DR3/DR4-DQ8 combination, because the two variants together amplify the immune system’s tendency to misfire. Subtle differences matter here: DR4 paired with DQ8 is strongly linked to type 1 diabetes, while DR4 paired with a closely related variant called DQ7 is actually protective, with risk dropping to about one-third of average.
Genes Beyond HLA
HLA genes account for roughly half the genetic risk for type 1 diabetes, but dozens of other genes contribute smaller effects. These genes affect either immune cell behavior or the health of insulin-producing beta cells in the pancreas. A gene called PTPN22 is one of the most consistently linked to the disease. It influences how easily immune cells become activated, and carrying its risk variant increases the chance of progressing from early immune warning signs (autoantibodies in the blood) to a full clinical diagnosis. Another gene, INS, affects how much insulin the thymus gland produces during early development. The thymus is where immune cells learn to tolerate your own body’s proteins. If less insulin is present during this training period, the immune system may fail to learn that insulin-producing cells are not threats.
Other contributing genes include PTPN2, STAT4, and ERBB3, each nudging risk in different ways at different stages. Some increase the chance of developing the first autoantibodies, while others speed the progression from autoantibodies to diabetes itself. No single one of these genes is powerful enough to cause the disease on its own, but collectively they shape whether someone with high-risk HLA genes actually develops type 1 diabetes or lives their entire life without it.
Risk by Family Member
If you have type 1 diabetes and want to know your child’s risk, the numbers depend on which parent is affected and when they were diagnosed. According to the American Diabetes Association, a father with type 1 diabetes passes along roughly a 1 in 17 chance (about 6%). A mother with type 1 diabetes passes along a 1 in 25 chance (4%) if the child was born before she turned 25, dropping to 1 in 100 (1%) if the child was born after age 25. If either parent was diagnosed before age 11, the child’s risk roughly doubles. When both parents have type 1 diabetes, the risk climbs to between 1 in 10 and 1 in 4.
For siblings, HLA matching is the critical factor. Research published in PNAS tracked siblings of children with type 1 diabetes and found striking differences based on how many HLA gene copies they shared with their affected sibling. Among siblings who carried the high-risk DR3/DR4-DQ8 combination and shared both HLA copies with their sibling, 55% developed diabetes by age 12. Siblings who shared zero or one copy had only a 5% risk by the same age. Even among those who shared both copies but didn’t carry the specific DR3/DR4-DQ8 combination, the risk was a more moderate 25% by age 12.
For context, the risk in the general population with no family history is roughly 0.4%, or about 1 in 250.
What Twin Studies Reveal
Identical twins share virtually all their DNA, so if type 1 diabetes were entirely genetic, both twins would always develop it. They don’t. Most identical twin pairs are actually discordant, meaning only one twin is affected. Concordance rates (both twins developing the condition) range from about 30% to 70% depending on the study and follow-up period, with longer follow-up catching more late-onset cases. The gap between 100% and the observed concordance rate represents the space where environment matters.
Interestingly, concordance varies depending on which risk genes the twins carry. Twins with the high-risk insulin gene variant are more likely to both develop diabetes than twins without it, confirming that even within identical twin pairs, the specific genetic “load” influences whether the disease breaks through.
Environmental Triggers in Genetically Susceptible People
Carrying risk genes is necessary but not sufficient. Something in the environment has to activate the autoimmune process. Viral infections are the most studied trigger, particularly enteroviruses (a common family that includes coxsackieviruses). These infections appear to accelerate autoimmunity through several pathways.
The most discussed mechanism is molecular mimicry: some viral proteins look structurally similar to proteins on insulin-producing beta cells. When the immune system ramps up to fight the virus, it may also begin attacking beta cells that share those structural features. A second pathway involves direct infection of the pancreatic islets, where viruses damage beta cells and trigger inflammation that draws immune attention to the area. A third involves persistent or recurring infections that keep the immune system in a state of chronic activation, increasing the odds that self-tolerance breaks down over time.
Beyond viruses, early dietary exposures have been investigated. The early introduction of gluten has been linked to increased risk in some studies, though the evidence is less definitive than for viral triggers. Rotaviruses and certain herpes viruses, including cytomegalovirus, have also been implicated.
Variation Across Ethnic Backgrounds
Type 1 diabetes rates and genetic risk profiles vary across populations. The condition is most common in people of Northern European descent, particularly Scandinavian populations, and less common in East Asian and sub-Saharan African populations. Part of this difference traces back to how frequently the high-risk HLA variants appear in different ethnic groups.
However, the genetic picture in non-European populations is still incomplete. Most large-scale genetic studies have been conducted in people of European ancestry, and the genetic risk scores developed from those studies don’t always predict type 1 diabetes as accurately in other populations. This is an important gap, because the disease does occur across all ancestries, and the contributing gene variants may differ in ways that current tools don’t fully capture.
What This Means in Practical Terms
Type 1 diabetes is strongly influenced by genetics but is not predetermined by them. The majority of people who develop type 1 diabetes have no close family member with the condition, which means that common gene variants circulating in the general population can combine to create risk even without an obvious family pattern. At the same time, most children born to a parent with type 1 diabetes will not develop it themselves.
If you have a family history and want to assess your child’s risk more precisely, screening programs exist that test for HLA genotype and autoantibodies. The presence of two or more autoantibodies in the blood is a strong predictor that clinical diabetes will eventually develop, and early identification can open the door to treatments that delay onset. The TrialNet Pathway to Prevention Study is one of the largest screening programs available to relatives of people with type 1 diabetes in the U.S.